Gene therapy for deafness approved

Science | AAAS·Apr 23

✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source

A gene therapy for deafness has been approved, marking a historic development in the treatment of genetic hearing loss. The therapy, which has been shown to restore hearing in children with a rare condition, has been approved by the FDA and will be provided for free by Regeneron. The treatment has demonstrated long-term hearing restoration in clinical trials, potentially opening up a new era in the treatment of inherited deafness.

Full coverage

FDA approves first gene therapy for inherited deafness, shown to restore hearing for children with rare condition

CNN·Apr 23

Hearing Restoration From Gene Therapy for Inherited Deafness Lasts Years, New Trial Results Show

Harvard Medical School·Apr 23

FDA Approves First-Ever Gene Therapy For Deafness, Opening Door To New Era

Forbes·May 19

FDA approval of Regeneron’s hearing loss gene therapy breaks barriers

BioSpace·Apr 23

Regeneron Nets Accelerated Approval From FDA for Otoferlin-Related Hearing Loss Gene Therapy Lunsotogene Parvec

CGTLive®·Apr 24

View original report at Science | AAAS ↗

Fetching the latest headlines…